RxDoctor Payments Data

Zoila Congleton

Family · Woodbridge, VANPI 1336152198

Payments from drug & device makers

$2,361in general payments, 2019–2025

Across 117 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$822
  • Lilly USA, LLC$284
  • AbbVie$253
  • Amgen$114
  • Biohaven Pharmaceuticals, Inc.$86
  • GSK$81
  • plus $721 from 21 others

What the payments were for

  • Food & beverage$2,34799%
  • Entertainment$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,361 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$60,026
Medicare patients
244
Services billed
872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin16$24,229
JanuviaSitagliptin Phosphate13$16,432
OzempicSemaglutide14$13,210
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,251
Duloxetine Hcl31$1,199
Levothyroxine Sodium88$1,195
Atorvastatin Calcium109$1,072
Rosuvastatin Calcium64$923
Albuterol Sulfate HfaAlbuterol Sulfate46$902
Potassium Chloride40$744
Losartan Potassium74$632
Ventolin HfaAlbuterol Sulfate11$615
Montelukast Sodium36$602
Gabapentin92$593
Risedronate Sodium11$542

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$44$16,43213 claims
Novo NordiskOzempic$822$13,21014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.

Other family in Woodbridge

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →